Previous Page  19 / 22 Next Page
Information
Show Menu
Previous Page 19 / 22 Next Page
Page Background

Page 45

Notes:

conferenceseries

.com

Volume 7, Issue 4 (Suppl)

Otolaryngology

ISSN: 2161-119X Otolaryngology, an open access journal

Aesthetic Medicine & ENT Conference 2017

July 06-08, 2017

July 06-08, 2017 Kuala Lumpur, Malaysia

International Conference on

Aesthetic Medicine and ENT

Management of erythema and flushing in patients with erythematotelangiectatic rosacea

Jeffery Lim

Aesthetic Medicine Academy Asia, Malaysia

R

osacea is a chronic inflammatory skin disorder which may present with transient or persistent erythema, telangiectasia,

inflammatory papules and pustules, phymatous changes and/or have ocular involvement (e.g., blepharitis, keratitis,

episcleritis, conjunctivitis). Patients may also report a burning or stinging sensation over the affected areas. The condition may

be aggravated by the consumption of spicy food, hot food/drinks, alcohol consumption, use of topical/oral corticosteroids,

exposure to heat (saunas, hot sun) or physical activities such as exercise. Patients with the erythematotelangiectatic variant of

rosacea often seek treatment for persistent erythema, increased sensitivity to cosmetics and topical products as well as pain

and discomfort. While there have been no single effective treatment for rosacea, there exists numerous options for treatment.

The objective of this presentation is to identify effective options to manage persistent or recalcitrant erythema in patients

with rosacea. Treatment options include topical therapy, oral medication, intradermal injectable therapy and laser & light

treatments. Topical therapy options that may be beneficial include topical metronidazole 1% gel, azelaic acid 20% cream,

permethrin 5% cream, ivermectin 1% cream, brimonidine tartrate 0.33% gel and oxymetazoline hydrochloride 1% cream.

Oral medications that have been prescribed include tetracyclines, metronidazole, isotretinoin, clonidine, beta blockers (e.g.,

carvedilol), ondansetron, naloxone and selective serotonin re-uptake inhibitors (SSRIs). Intradermal botulinum toxin A has

been reported to be helpful in reducing erythema associated with rosacea. Intense pulsed light, copper bromide laser, pulsed

dye laser or long pulsed Nd:YAG laser may be considered in recalcitrant cases.

thelimster@gmail.com

Jeffery Lim, Otolaryngology 2017, 7:4 (Suppl)

DOI: 10.4172/2161-119X-C1-019